west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "卢红" 3 results
  • IDEAS ABOUT REGISTRATION FOR SODIUM HYALURONATE FACIAL DERMA FILLERS

    ObjectiveTo review the registration and technical data for sodium hyaluronate facial derma fillers. MethodsRecent literature concerning registration for sodium hyaluronate facial derma fillers was reviewed and analyzed. ResultsThe aspects on registration for sodium hyaluronate facial derma fillers include nominating the product, dividing registration unit, filling in a registration application form, preparing the technical data, developing the standard, and developing a registration specification. ConclusionThe main difficulty in registration is how to prepare the research data of that product, so the manufacturers need to enhance their basic research ability and work out a scientific technique routing which could ensure the safety and effectiveness of the product, also help to set up the supportive documents to medical device registration.

    Release date:2016-08-31 05:39 Export PDF Favorites Scan
  • The clinical analysis of intraocular pressure elevation after pars plana vitrectomy

    Objective To investigate the risk factors of the intraocular pressure (IOP) elevation after pars plana vitrectomy (PPV). Methods Eighty-eight patients (88 eyes) of postoperative ocular hypertension in a series of 339 patients who had undergone PPV with normal ocular pressure before operation were retrospectively studied. The ocular pressures in both preoperative and postoperative periods were detected by NCT examination, and the ocular hypertension was decided on the level of ≥25 mm Hg. The relationships of occurence of the time of onset and duration of persistence of postoperative ocular hypertension with the different kinds of primary diseases, the techniques of operation, and the condition whether or not the affected eyes had formerly accepted surgical intervention, were analyzed. Results The IOP elevation occures mostly within 1 to 2 weeks postoperatively (77 eyes, 87.5%). In 65 cases (65 eyes) IOP returned to normal in 1 week, and in another 14 cases (14 eyes) in 1 month after treatments. Six patients’ (6 eyes ) IOP was under 25 to 30 mm Hg with the medicine. With sustained elevation of IOP over 4 to 6 months, 3 cases (3 eyes ) lost or almost lost their vision finally. The probability of postoperative IOP elevation in the patients suffered from the retinal detachment with proliferative vitreoretinopathy (PVR) ≥grade C-2 was the highest in all the patients in our study (38.2%, P<0.05). The patients who had intraocular surgery before were more likely to have IOP elevation than the ones without intraocular surgery (P<0.05). Placement of a scleral buckle, use of expansile gases or silicone oil injection and scatter endophotocoagulation intraoperatively were related to the postvitrectomy IOP elevation (γ=0.829, P<0.001). Conclusions The previous intraocular surgeries, certain primary eye diseases and combined ocular procedures are the risk factors of IOP elevation after PPV. (Chin J Ocul Fundus Dis, 2002, 18: 106-108)

    Release date:2016-09-02 06:01 Export PDF Favorites Scan
  • 透明质酸钠类面部注射产品临床试验设计思路

    近年来,企业研发用于除皱的透明质酸钠类面部注射产品日益增多。此类产品在国内按照第三类医疗器械进行管理,即属于管理类别最高的医疗器械,注册申报时需提交规范的临床试验资料以支持其安全性和有效性。因此,对于此类产品如何进行科学的临床试验设计,如何选择合理的临床评价标准,如何按照不同的产品适应证界定临床试验单元,如何对临床数据进行充分的分析,以及对于已上市的产品如何进行临床随访数据的收集,则是企业和临床试验机构共同关注的问题。

    Release date:2016-09-08 09:18 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content